NewsFeed Voices Science Insight Innovation
November, 2025
November 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
Jon Faldasz: Why Aren’t We Better at Achieving Therapeutic Warfarin Control?
Jon Faldasz/LinkedIn
Nov 21, 2025, 08:55

Jon Faldasz: Why Aren’t We Better at Achieving Therapeutic Warfarin Control?

Jon Faldasz, Senior Director of Product and Customer Experience at InsightRX, posted on LinkedIn:

”Ok I know warfarin is the stinky kid in the corner, but it’s not going anywhere. So why aren’t we better at achieving time in therapeutic range?

Could it be:
– We think that 40% time in range is “good enough”? (data argues otherwise)
– Low warfarin use means we think this problem isn’t significant (patients would argue otherwise)
– We think that the problem is unsolvable? (Anticoagulation specialists argue otherwise)

I would love to get some comments to bring with me to the Anticoagulation Forum Stewardship Summit. Don’t make me call you out, people.”

Jon Faldasz

Stay updated with Hemostasis Today.

Anticoagulation Anticoagulation Forum Health Hematology Hemostasis Hemostasis Today Jon Faldasz Medicine thrombosis Warfarin
NewsFeed